Mr. Yang Gao | Cholangiocarcinoma | Best Researcher Award

Mr. Yang Gao | Cholangiocarcinoma | Best Researcher Award

Tongji Medical College Huazhong University of Science and Technology | China

Author Profile

Scopus

šŸ“˜ Dr. Yang Gao: A Dedicated Leader in Hepatobiliary Oncology Research

Full Name: Yang Gao

Gender: Male

Designation: Attending Doctor; Lecturer

Department: Department of Hepatobiliary Surgery

Institution/Organization: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Qualification: Doctor (MD, PhD)

Area of Specialization: Hepatobiliary Oncology and Cancer

Sub Division: Oncology Therapeutics and Novel Approaches

Date of Birth: October 25, 1987

Onboard Date: July 1, 2018

Total Experience:

  • Work: 5 years
  • Doctor: 3 years
  • Master: 3 years
  • Bachelor: 5 years

Contact Information:

šŸŽ“ Education and Training

  • 2015.09-2018.06: MD, PhD in Hepatobiliary Surgery from Tongji Medical College, Huazhong University of Science and Technology
  • 2012.09-2015.06: Master’s in Hepatobiliary Surgery from Tongji Medical College, Huazhong University of Science and Technology
  • 2007.09-2012.06: Bachelor’s in Clinical Medicine from Shandong Second Medical University

šŸ„ Professional Experience

2018.07 – Present: Attending Physician and Lecturer at the Affiliated Union Hospital of Tongji Medical College, Huazhong University of Science and Technology.

  • Proficient in surgical treatments for benign and malignant tumors of the liver and gallbladder, including gallstones.
  • Expert in minimally invasive laparoscopic surgery, especially for liver cancer, anatomical liver resection surgery, and complex biliary surgeries.
  • Skilled in the comprehensive treatment of hepatocellular carcinoma and biliary tract cancer, including intervention, targeting, and immunotherapy.

šŸ“Š Research, Innovations, and Extensions

  • Research Projects Completed and Ongoing: 6
  • Citation Index in Scopus/Web of Science/PubMed: 61
  • Total Project Cost: $414,000 USD
  • Patents: 5 published and under process
  • Journals Published (SCI and SCIE index): 12
  • Journals Published (Scopus/Web of Science/PubMed index): 13
  • Countries Visited for Research: 1
  • Cumulative Impact Factor (last 3 years): 55
  • H-index: 5
  • Invited Speaker/Resource Person: 1
  • Member of Professional Bodies: 10

šŸ† Awards and Recognitions

  • Total Number of Awards and Recognitions: 1
  • Award Category: Best Researcher Award

🌐 Contribution to Research & Development, Innovations, and Extension Activities On Cholangiocarcinoma

Dr. Yang Gao has significantly contributed to the field of Tumor Research & Development, Innovations, and Extension Activities. His work focuses on advancing the understanding of tumor biology, therapeutic interventions, and patient care outcomes, particularly in hepatobiliary malignancies. Dr. Gao collaborates with interdisciplinary teams to discover novel biomarkers, therapeutic targets, and treatment modalities aimed at improving patient outcomes and quality of life.

Dr. Gao has played a pivotal role in translating research findings into clinical practice by fostering partnerships with industry stakeholders, academic institutions, and healthcare providers. His efforts have led to the development and implementation of cutting-edge technologies and treatment approaches in oncology.

Moreover, Dr. Gao actively engages in extension activities to disseminate knowledge and promote cancer prevention, early detection, and treatment options within the community. Through educational workshops, public seminars, and outreach programs, he empowers patients, caregivers, and healthcare professionals with the information and resources needed to combat cancer effectively. His dedication to cancer research, innovation, and community outreach underscores his commitment to making a meaningful impact in the fight against cancer.

šŸ“œ Personal and Research Proofs

  • Institute ID Number: 2018XH0171
  • Certificate Number (Education Proof): 1048722018100647
  • Passport Number: E28938966
  • Government ID: 370181198710251116

āœ… Declaration

Dr. Yang Gao, authenticate that to the best of my knowledge, the information given in this form is correct and complete. If any material information is found to be concealed, my application shall be summarily terminated without notice. I have read and agree to the terms and conditions and other policies of the International Research Awards.

Notable Publication

    • Authors: Yang Gao, et al.
    • Journal: Journal of Hepatology Research
    • Volume: 35
    • Year: 2021

 

 

    • Authors: Yang Gao, et al.
    • Journal: Cancer Research
    • Volume: 80
    • Year: 2022

 

    • Authors: Yang Gao, et al.
    • Journal: Annals of Surgery
    • Volume: 270
    • Year: 2021

 

    • Authors: Yang Gao, et al.
    • Journal: International Journal of Surgery
    • Volume: 76
    • Year: 2020

Prof. Sobhi Gomha | Chemotherapy | Best Researcher Award

Prof. Sobhi Gomha | Chemotherapy | Best Researcher Award

Islamic University of Madinah | Saudi Arabia

Author Profile

Scopus

Google Scholar

Orcid id

Personal Data:

  • Name: Sobhi Mohamed Gomha
  • Date of Birth: 1972
  • Place of Birth: Fayoum, Egypt
  • Nationality: Egyptian
  • Gender and Marital Status: Male, Married
  • Occupation: Professor of Organic Chemistry
  • Institutions:
    • Faculty of Science, Cairo University, Giza, Egypt.
    • Faculty of Science, Islamic University of Madinah, Madinah, Saudi Arabia.
  • Addresses:
    • Permanent: Faculty of Science, Cairo University, Giza 12613, Egypt; Chemistry Department
    • Resident: Faculty of Science, Islamic University of Madinah, Madinah 42351, Saudi Arabia.
  • Contact:

Certificates and Qualifications:

  • B.Sc. (Chemistry): 1995, Cairo University – Faculty of Science.
  • Pre-master courses: 1996-1997
  • M.Sc. (Organic Chemistry): 2002, Cairo University – Faculty of Science.
  • Ph.D. (Organic Chemistry): 2006, Cairo University – Faculty of Science.
  • Associate Professor: January 2012, Cairo University – Faculty of Science.
  • Full Professor: January 2017, Cairo University – Faculty of Science.

Research Interests:

  • Green Synthesis: Focus on the green synthesis of novel heterocyclic compounds using eco-friendly technologies like Microwave Irradiation, Ultrasonic radiation, Grinding, and Ionic Liquids.
  • Applications: Biological and industrial applications with an emphasis on reducing hazardous substances and energy usage.

Online Profiles:

Publications and Metrics:

  • Total Publications: 270 (257 published papers: 240 research papers, 17 review articles) + 13 books.
  • Citations:
    • Google Scholar: 6730
    • Scopus: 5600
    • Web of Science: 6280
    • ResearchGate: 6050
  • Highly Cited Papers:
    • Google Scholar: 319
    • Scopus: 269
    • Web of Science: 250
    • ResearchGate: 269
  • H-index:
    • Google Scholar: 48
    • Scopus: 44
    • Web of Science: 44
    • ResearchGate: 43
  • i10-index: 176 (Google Scholar)

Teaching Courses:

  • General Chemistry, Aliphatic Organic Chemistry, Aromatic Organic Chemistry, Heterocyclic Chemistry, Functional Organic Chemistry, Physical Organic Chemistry, Biomolecules, Natural products, Organometallic Chemistry, Physical Pharmacy, Stereochemistry, Biochemistry, Advanced Heterocyclic Chemistry, Chemistry of Drugs, Green and Environmental Chemistry, Reactions and Mechanisms of Aliphatic Compounds, Spectroscopy (MS, IR, NMR, UV), Basic principles of Organic Chemistry for Pre-Pharmacy, Pre-Dental, Pre-Veterinary students, Practical Organic Chemistry for undergraduate students, Field Training, Graduation Project.

Professional Memberships and Achievements:

  • Scientific Societies:
    • Egyptian Society of Heterocyclic Chemistry (EHCS)
    • Performance appraisal and development committee (Cairo University)
    • Scientific culture committee (Cairo University)
    • Research Committee of the article and graduation projects (Cairo University)
    • Quality Committee, Department of Chemistry (Cairo University and Islamic University of Madinah)
    • Training and Development Committee, Faculty of Science, Islamic University of Madinah
    • Head of Chemistry Department, Faculty of Science, Islamic University of Madinah
    • Egyptian National Bioinformatics Network (BioNetMasr)
    • Scientific Research Deanship Council at the Islamic University
    • Sustainability Unit at the Islamic University
    • Supervised and launched academic programs and projects in Chemistry
    • Participated in numerous scientific and quality events

Conferences Attended:

  • Participated and presented in various international and national conferences, such as Biannual conference on chemistry (Cairo University), International conferences in Egypt, UAE, Morocco, and Saudi Arabia, Heterocyclic Chemistry meetings, Scientific Research Weeks, and Quality Weeks.

Experiences:

  • Proficient in PC software (ChemDraw, Excel, Word, PowerPoint)
  • Expertise in Mass Spectra, NMR, Organic Synthesis
  • Completed various training courses in IR, NMR, UV, GCMS, microanalytical instruments, effective presentation, new trends in teaching (E-Learning), effective teaching, credit hours education, scientific publications, utility of technology in teaching, and strategic planning.

Editorial and Reviewer Roles:

  • Editorial Board Member for 42 Journals: Including Molecules, Crystals, Scientific Reports, Mini-Reviews in Medicinal Chemistry, Current Medicinal Chemistry, and various other international journals.
  • Reviewer for 138 Journals: Including ACS Chemical Neuroscience, Acta Pharmaceutica Sinica B, Analytical Chemistry Letters, Anticancer Agents in Medicinal Chemistry, Arabian Journal of Chemistry, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, and many more.

Reviewing PhD Theses:

  • Reviewed several PhD theses on topics like environmental cost accounting, synthesis and biological evaluation of novel compounds, green chemistry methodologies, and heterocyclic ring synthesis.

Reviewing for Promotions:

  • Reviewed scientific production for the promotion of faculty members from various universities, including Imam Abdulrahman Bin Faisal University, University of Bisha, Northern Border University, Taibah University, Taif University, and Tabuk University.

Languages:

  • English (Good), French (Fair), German (Fair)

Supervision:

  • Supervisor for 17 MSc and 9 PhD theses.

Research Projects:

  • Engaged in multiple research projects funded by various institutions, focusing on green synthesis, characterization, biological evaluation of novel compounds, separation of rare earth elements, and innovative optical organic compounds for solar cells.

Awards and Recognition:

  • Best paper in heterocyclic chemistry from the Egyptian Heterocyclic Chemistry Society (E.H.C.S) for 2015.
  • Included in the list of the World’s Top 2% Scientists by Stanford University for the years 2019, 2020, and 2021.

Notable Publication:

Dr Jianjun Xu | Hepatobiliary Oncology and Cancer | Best Researcher Award

Dr Jianjun Xu | Hepatobiliary Oncology and Cancer | Best Researcher Award

Union Hospital, Tongii Medical | China

Author Profile

Scopus

Orcid id

šŸ„ Dr. Jianjun Xu: Pioneering Hepatobiliary Oncology Specialist

šŸ‘Øā€āš•ļø Full Name: Jianjun Xu

šŸ… Designation: Attending Doctor

šŸØ Department:

  • Department of Hepatobiliary Surgery
  • Center for Liver Transplantation

šŸŽ“ Qualification: Doctor

šŸ”¬ Area of Specialization: Hepatobiliary Oncology and Cancer

šŸ’” Sub Division: Oncology Therapeutics and Novel Approaches

šŸ•’ Total Experience:

  • Work for 2 years
  • Doctor for 3 years
  • Master for 3 years
  • Bachelor for 5 years

 


šŸŽ“ Education

šŸ“š 2011-2016: Bachelor of Clinical Medicine, School of Medicine, Nanchang University.

šŸŽ“ 2016-2019: Master of Surgery, Tongji Medical College, Huazhong University of Science and Technology.

šŸ« 2019-2022: Doctor of Surgery, Tongji Medical College, Huazhong University of Science and Technology.


šŸ„ Experience

🩺 July 2022 to Present: Attending Doctor at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Wuhan 430022, China.


šŸ”¬ Contributions to Research, Innovations, and Extension Activities On Hepatobiliary Oncology and Cancer

Throughout his tenure, Dr. Jianjun Xu has made significant contributions to Tumor Research & Development, Innovations, and Extension Activities. Actively participating in research projects, he has advanced the understanding of tumor biology, therapeutic interventions, and patient care outcomes. Leveraging his expertise in hepatobiliary malignancies, Dr. Xu collaborates with interdisciplinary teams to identify novel biomarkers, therapeutic targets, and treatment modalities, aiming to improve patient outcomes and quality of life.

Dr. Xu has also been involved in innovative initiatives to translate research findings into clinical practice. By fostering partnerships with industry stakeholders, academic institutions, and healthcare providers, he has facilitated the development and implementation of cutting-edge technologies and treatment approaches in oncology.

In addition to his research endeavors, Dr. Xu actively engages in extension activities to disseminate knowledge and promote awareness of cancer prevention, early detection, and treatment options within the community. Through educational workshops, public seminars, and outreach programs, he empowers patients, caregivers, and healthcare professionals with the necessary information and resources to combat cancer effectively. His dedication to advancing cancer research, innovation, and community outreach underscores his commitment to making a meaningful impact in the fight against cancer.

NOTABLE PUBLICATION:

Assist Prof Zhe Xu | Foodborne osteogenic peptides | Best Researcher Award

Assist Prof Zhe Xu | Foodborne osteogenic peptides| Best Researcher Award

Dalian Minzu University | China

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS šŸŽ“

Zhe Xu’s academic journey commenced with a Bachelor of Science degree in Food Science from Dalian Polytechnic University, China, from 2011 to 2015. This foundational period laid the groundwork for his future pursuits in the field of food science and technology. Following his undergraduate studies, he continued to pursue higher education, culminating in a Ph.D. in Food Science from the same institution, spanning from 2015 to 2020. These formative years provided Xu with a comprehensive understanding of food science principles, research methodologies, and a solid academic foundation for his subsequent endeavors.

PROFESSIONAL ENDEAVORS 🌟

Xu’s professional journey is characterized by a series of significant roles and experiences that have contributed to his growth and expertise in the field. From 2021 onwards, he has served as an Assistant Professor at the School of Life Science, Dalian Minzu University, China, where he has actively engaged in teaching, research, and academic leadership. Concurrently, he embarked on a postdoctoral position at the Institute of Bast Fiber Crops & Center of Southern Economic Crops, Chinese Academy of Agricultural Sciences, China, focusing on research related to food-derived functional factors. Additionally, since 2023, Xu has held the position of Visiting Professor at the University of Alberta, Canada, further expanding his global academic network and collaborations.

CONTRIBUTIONS AND RESEARCH FOCUS ON FOODBORNE OSTEOGENIC PEPTIDESšŸ“š

Xu’s research endeavors encompass a diverse range of topics within the realm of food science and technology. His primary focus lies in the screening and identification of osteogenic protein peptides from food sources, aiming to uncover potential therapeutic agents for bone health. Furthermore, he delves into the identification and activity mechanism analysis of food-derived functional factors, exploring their implications for human health and nutrition. Additionally, Xu investigates the digestive properties of food components in the gastrointestinal tract, shedding light on crucial aspects of digestion and nutrient absorption. Through his research, Xu contributes valuable insights to the field, addressing pressing challenges and advancing scientific knowledge.

IMPACT AND INFLUENCE 🌐

Xu’s contributions to the field of food science have left a notable impact on both academia and industry. His research findings have been disseminated through publications in reputable journals, presentations at international conferences, and collaborations with esteemed institutions worldwide. By elucidating the potential health benefits of food-derived bioactive compounds and unraveling the mechanisms underlying their physiological effects, Xu’s work has the potential to inform dietary recommendations, pharmaceutical development, and clinical practice, ultimately benefiting global health and well-being.

ACADEMIC CITATIONS šŸ“–

Xu’s research output has garnered significant attention within the academic community, as evidenced by citations in peer-reviewed publications and scholarly discourse. His work serves as a foundational resource for researchers, educators, and practitioners in the field of food science, providing valuable insights and avenues for further exploration. Through his innovative approach and rigorous methodology, Xu has established himself as a respected figure in the academic landscape, contributing to the advancement of knowledge and understanding in his field.

LEGACY AND FUTURE CONTRIBUTIONS HIGHLIGHT šŸš€

As Xu continues to navigate his academic and professional journey, his legacy is shaped by a commitment to excellence, innovation, and collaboration. With a steadfast dedication to advancing scientific knowledge and addressing global challenges in food science and technology, Xu’s future contributions hold the promise of transformative impact. Through continued research endeavors, mentorship of aspiring scholars, and engagement with diverse stakeholders, Xu aims to leave a lasting legacy that transcends disciplinary boundaries and fosters positive change in society.

NOTABLE PUBLICATION:

Prof Shengping Hou |Ā Immunotherapy | Best Researcher Award

Prof Shengping Hou | Immunotherapy | Best Researcher Award

Beijing Tongren Hospital, Capital Medical University | China

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Shengping Hou, Ph.D., began his academic journey at Sun Yat-sen University in China, where he obtained his Ph.D. in Ocular Immunology in 2009. His doctoral research laid the foundation for his future contributions to ocular immunology, particularly focusing on the genetic aspects of ocular diseases. Following his Ph.D., Dr. Hou furthered his expertise with a postdoctoral fellowship at the University of California, San Francisco, specializing in Ocular Stem Cell Biology, which he completed in 2016.

PROFESSIONAL ENDEAVORS

Dr. Hou’s professional career commenced at The First Affiliated Hospital of Chongqing Medical University, where he served as an Associate Professor from 2009 to 2015. He was later promoted to Professor, a position he held until 2023. During his tenure, he was also a key figure at the Chongqing Key Laboratory of Ophthalmology. In 2023, Dr. Hou transitioned to Beijing Tongren Hospital, where he now serves as the Director of the Beijing Institute of Ophthalmology and continues his professorship at Capital Medical University.

CONTRIBUTIONS AND RESEARCH FOCUS ON IMMUNOTHERAPY

Dr. Hou’s research has primarily centered on the genetic and immunological underpinnings of ocular diseases, particularly uveitis and Behcet’s disease. His work has involved extensive genetic studies, including the investigation of VKH syndrome and the role of complement component 4 copy number variants in ocular pathogenesis. His notable projects have been consistently supported by grants from the National Natural Science Foundation and other key R&D initiatives in China.

IMPACT AND INFLUENCE

Dr. Hou’s contributions have earned him significant recognition in the scientific community. He has been honored with several prestigious awards, including the First Prize for Achievement in Science and Technology from both Chongqing and the Chinese Health Ministry. His research findings have been widely disseminated through invited lectures and presentations at major international conferences, enhancing the understanding of genetic influences in ocular diseases.

ACADEMIC CITATIONS

Throughout his career, Dr. Hou has been an active member of the Chinese Ocular Immunology Society and has served as an ad hoc reviewer for several high-impact journals such as Nature Reviews Rheumatology, Advanced Science, and eBioMedicine. His work has been extensively cited by peers, reflecting the significant impact of his research on the field of ocular immunology.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Hou’s legacy in the field of ophthalmology is marked by his dedication to uncovering the genetic mechanisms underlying ocular diseases. As the Director of the Beijing Institute of Ophthalmology, he continues to lead groundbreaking research and mentor the next generation of scientists. His future contributions are poised to further advance the understanding and treatment of ocular conditions, solidifying his status as a leading figure in ophthalmic research.

NOTABLE PUBLICATION:

Assist Prof Dr Matthias Bartneck | Cancer Therapy | Best Researcher Award

Assist Prof Dr Matthias Bartneck | Cancer Therapy | Best Researcher AwardĀ 

RWTH Aachen University | Germany

AUTHOR PROFILE

Scopus

Google Scholar

Orcid ID

EARLY ACADEMIC PURSUITS

Priv.-Doz. Dr. rer. nat. Matthias Bartneck embarked on his academic journey with a diploma in Biology from the University of Bielefeld (2001-2006). His diploma thesis focused on gene expression and metabolite profiling of human primary mamma carcinomas, under the supervision of Dr. Anke Becker. He continued his academic pursuits with a Doctor of Natural Sciences degree from RWTH Aachen (2007-2010), where his research centered on the interactions of human primary immune cells with various nanomaterials. This work was supervised by Prof. Gabriele Zwadlo-Klarwasser.

PROFESSIONAL ENDEAVORS

Dr. Bartneck’s professional career has been marked by a series of significant positions and collaborations. He has been employed at the Medical Faculty 10, Gastroenterology, and Faculty 1 Leibniz Institute for Interactive Materials DWI/RWTH Institute for Technical and Macromolecular Chemistry (ITMC) since 2023. He has also served as a guest lecturer at the Max Planck Research Training School Matter to Life. From 2018 to 2022, he was a lecturer at the Center for Functional Magnetic Materials, Immanuel Kant Baltic Federal University in Kaliningrad, Russia. Additionally, Dr. Bartneck has been a group leader at the Medical Faculty, Medical Clinic III, RWTH Aachen since 2014, focusing on immunomodulatory nanomedicine for inflammatory diseases and cancer.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER THERAPY

Dr. Bartneck’s research has significantly advanced the fields of gastroenterology, hepatology, and nanomedicine. His work has delved into the development of novel nanocarriers for treating liver diseases and cancer, as well as the modulation of immune cell migration and activation in inflammatory diseases. His research has been supported by substantial funding, including grants from the German Research Foundation (DFG) and the Wilhelm Sander Foundation. His contributions include over 61 publications, 18 as the first author and 4 as the last author, along with 7 book chapters and 9 reviews.

CITATIONS

  • ZitateĀ  Ā  Ā  Ā  Ā  Ā 4439
  • h-indexĀ  Ā  Ā  Ā  35
  • i10-indexĀ  Ā  Ā 49

IMPACT AND INFLUENCE

Dr. Bartneck’s research has had a profound impact on the scientific community, evidenced by a total of 3764 citations and an H-index of 32. His expertise in immunomodulatory nanomedicine has led to collaborations with prestigious institutions and industry partners, including Bayer Healthcare, Novartis, and Precision Nanosystems. His work has been recognized with several fellowships and awards, such as the Young Investigator Award from the European Association for the Study of the Liver (EASL).

ACADEMIC CITES

Dr. Bartneck has held numerous academic positions and provided significant contributions to teaching and mentoring. He has supervised a wide range of students, from bachelor to doctoral levels, across multiple disciplines including medicine, chemistry, and biology. His teaching roles have included lectures and practical courses in materials science, blood and defense, and inflammation at RWTH Aachen.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Bartneck’s legacy is marked by his interdisciplinary approach and dedication to advancing nanomedicine and immunology. He has secured research funds exceeding €1,500,000 in 2022 alone for the development of novel lipid-based nucleic acid therapeutics. His future contributions are expected to further enhance the understanding and treatment of inflammation-associated diseases and cancer. His continued collaborations with international academic and industry partners underscore his commitment to advancing scientific knowledge and innovation.

NOTABLE PUBLICATION:

 

Prof Lubna Tahtamouni | Cancer Cell Biology | Best Researcher AwardĀ 

Prof Lubna Tahtamouni | Cancer Cell Biology | Best Researcher AwardĀ 

The Hashemite University | Jordan

Author Profile

Scopus

Scholar

Orcid ID

Early Academic Pursuits

Lubna H. Tahtamouni began her academic journey at the University of Jordan, where she earned a B.Sc. in Biology in June 1997 and an M.Sc. in Biology in April 2000. Her Master's thesis, titled ā€œThe Etiological Factors Among 702 Infertile Jordanian Couples,ā€ was supervised by Hameed Al-Hajj, Ph.D. She further pursued a Ph.D. in Developmental Biology at Colorado State University, completing her thesis on ā€œThe Role of mDia1 During the Initiation of Polarization and Migration of Chick Embryo Cardiac Fibroblastsā€ under the guidance of James R. Bamburg, Ph.D.

Professional Endeavors

Dr. Tahtamouni has held numerous academic and administrative positions. She has been a Professor in the Department of Biology and Biotechnology at The Hashemite University in Zarqa, Jordan, since February 2020. Previously, she served as an Associate Professor and Assistant Professor in the same department. Her administrative roles include Chair of the Department of Biology and Biotechnology and Managing the Office of Externally Funded Projects at The Hashemite University. At Colorado State University, she has been an Affiliate Faculty in the Department of Biochemistry and Molecular Biology since August 2023 and served as a Senior Research Scholar and Co-director of the Molecular Biology and Biochemistry REU program.

Contributions and Research Focus on Cancer Cell Biology

Dr. Tahtamouni’s research primarily focuses on understanding the cellular alterations leading to cancer, with specific projects on cell migration, adhesion, metastasis, mitochondrial function, apoptosis, cytoskeleton-related proteins, and cell cycle and anti-tumor drug screening. Additionally, she investigates the role of actin dynamics, mediated by the protein cofilin, in neurodegenerative diseases using induced pluripotent stem cells to model these processes.

Impact and Influence

Dr. Tahtamouni’s contributions to science have been recognized with numerous awards and honors. She was named one of the World's 100 Most Inspirational and Influential Women by the BBC in 2016 and received the Women in Science Hall of Fame award from the US Embassy in Amman, Jordan, in 2015. Her work has earned her fellowships and scholarships from prestigious institutions such as the National Institutes of Health (NIH), the U.S. National Academy of Sciences, and the L'OREAL-UNESCO for Women in Science program.

Academic Cites

Throughout her career, Dr. Tahtamouni has been involved in significant academic publishing and editorial roles. She served as Lead Guest Editor for a special issue on ā€œMolecular Regulation of Cancer Cell Migration, Invasion and Metastasisā€ in Analytical Cellular Pathology and as an Assistant Editor for the Jordan Journal of Biological Sciences.

Legacy and Future Contributions

Dr. Tahtamouni’s legacy is marked by her dedication to advancing the understanding of cancer and neurodegenerative diseases. Her collaborative efforts span basic, translational, and clinical sciences, significantly impacting these fields. Looking forward, her continued research and mentorship are expected to contribute further to scientific advancements and the development of effective therapeutic strategies.

Teaching and Supervision

Dr. Tahtamouni has extensive teaching experience across various biology and biotechnology courses at The Hashemite University and Colorado State University. She has also supervised numerous training courses, particularly in assisted reproductive techniques and cytogenetics, contributing to the education and professional development of many students and researchers.

Notable Publication:

 

Assoc Prof Dr. Zhijie Xu | Chemotherapy | Best Researcher Award

Assoc Prof Dr. Zhijie Xu | Chemotherapy | Best Researcher AwardĀ 

Xiangya Hospital Central South University | China

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Zhijie Xu embarked on his academic journey with a solid foundation in medical laboratory science, earning his bachelor’s degree from Xiangya School of Medicine. His early interests focused on the mechanisms of disease at the cellular level, laying the groundwork for his future research endeavors.

PROFESSIONAL ENDEAVORS

Throughout his career, Zhijie Xu has held notable positions, including Associate Professor and Associate Chief Technician at Xiangya Hospital, Central South University. His professional roles have been complemented by his extensive involvement in editorial activities for prominent scientific journals, which underscores his influence in the field of oncology and pharmacology.

CONTRIBUTIONS AND RESEARCH FOCUS ON CHEMOTHERAPY

Zhijie Xu’s research has predominantly centered on the molecular and cellular mechanisms of cancer. His work has particularly focused on DNA-damage response, ubiquitination in human cancers, and cell autophagy related to radio-resistance in cancers. His contributions to understanding non-coding RNA and immunotherapy in lung cancers and gliomas are notable.

IMPACT AND INFLUENCE

With an H index of 30, Zhijie Xu’s research has had a significant impact on the scientific community. His findings have provided insights into the molecular underpinnings of cancer, influencing both basic and clinical cancer research. His editorial roles further amplify his influence, as he shapes the discourse in several high-impact journals.

ACADEMIC CITES

Zhijie Xu’s academic work is well-cited, reflecting the importance and relevance of his research. His contributions to understanding the complex mechanisms of cancer biology have been recognized and referenced by peers, solidifying his reputation in the scientific community.

LEGACY AND FUTURE CONTRIBUTIONS

Looking forward, Zhijie Xu aims to continue his groundbreaking research in cancer biology. His future work is expected to delve deeper into the mechanisms of cancer resistance and the development of novel therapeutic strategies. His ongoing projects and future initiatives are poised to further advance the field and contribute to the fight against cancer.

 

NOTABLE PUBLICATION:

Satish Mahadevan Srinivasan | Bioinformatics | Best Researcher Award

Dr. Satish Mahadevan Srinivasan | Bioinformatics | Best Researcher Award

Penn State Great | United States

AUTHOR PROFILE

Scopus

Scholar

Orcid ID

 

EARLY ACADEMIC PURSUITS

Satish Mahadevan Srinivasan began his academic journey with a Bachelor's degree in Information Technology from Bharathidasan University, Tiruchirappalli, Tamil Nadu, India, in May 2001. He further pursued a Master's degree in Industrial Engineering and Management from the Indian Institute of Technology (IIT), Kharagpur, in February 2005. His educational journey culminated with a Ph.D. in Information Technology from the University of Nebraska at Omaha in May 2010, where he specialized in Statistics, Data Mining, Computer and Information Science. His Ph.D. thesis focused on "Data Aggregation in Multi-Agent Systems in the Presence of Hybrid Faults."

PROFESSIONAL ENDEAVORS

Dr. Srinivasan's professional career commenced as a Junior Project Assistant at IIT Kharagpur, where he later became a Senior Project Assistant. He transitioned into academia and research with a Graduate Assistant role at the University of Nebraska at Omaha from August 2005 to December 2009. After completing his Ph.D., he served as a Postdoctoral Research Assistant at the University of Nebraska at Omaha and subsequently at the University of Nebraska Medical Center. His professional journey progressed at Penn State Great Valley (PSGV), where he started as a Tenure-track Assistant Professor in September 2013 and later became a Tenured Associate Professor in August 2019.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOINFORMATICS

Dr. Srinivasan has made significant contributions to various fields, including data mining, predictive analytics, machine learning, artificial intelligence, cybersecurity, software engineering, bioinformatics, and distributed computing. His notable research includes:

  • Protein Sequence Classification: Developed methods to identify class-specific motifs using n-grams, contributing to the understanding of sequence landscapes.
  • Metagenomic Study: Created MetaID, a tool for taxonomic and phylogenetic analysis of microbial communities, achieving near 99% accuracy in microbe identification.
  • Program Transformation: Developed Monarch, a tool for migrating Java source code to restricted JVMs used in embedded systems.

IMPACT AND INFLUENCE

Dr. Srinivasan's research has had a profound impact on various scientific domains. His work on protein sequence classification and metagenomic studies has advanced the fields of bioinformatics and genomics. The tools and methodologies he developed have been published in reputable journals like BMC Bioinformatics and BMC Genomics, reflecting their significance and influence.

ACADEMIC CITES

Dr. Srinivasan's scholarly work has been widely cited in academic literature, demonstrating the relevance and applicability of his research. His publications serve as valuable resources for researchers and practitioners in the fields of data mining, bioinformatics, and computational biology.

LEGACY AND FUTURE CONTRIBUTIONS

As a tenured associate professor, Dr. Srinivasan continues to mentor students and conduct cutting-edge research. His future contributions are likely to further the understanding and application of data mining, machine learning, and bioinformatics. His legacy is marked by his dedication to advancing knowledge and solving complex problems through interdisciplinary research.

NOTABLE PUBLICATION:

 

Prof. IsabellaCavalcanti – Cancer Science – Best Researcher Award

Prof. IsabellaCavalcanti - Cancer Science - Best Researcher Award

Federal University of Pernambuco (UFPE) - Brazil

Author Profile

Google ScholarĀ 

Scopus

Orcid

EARLY ACADEMIC PURSUITS

Isabella MacƔrio Ferro Cavalcanti began her academic journey by graduating in Biomedicine from the Federal University of Pernambuco (UFPE). Following this, she pursued a master's degree in Therapeutic Innovation at UFPE, delving into advanced studies in the field. She then proceeded to earn her doctorate in Biotechnology, further refining her expertise in biological sciences.

PROFESSIONAL ENDEAVORS

Dr. Cavalcanti's professional career has been marked by significant accomplishments. She specializes in Clinical Microbiology, obtaining further specialization at the University of Pernambuco (UPE). Currently, she serves as a professor at UFPE, where she contributes to the education and training of future professionals in the field. Her involvement extends to leadership roles within various post-graduate programs, emphasizing her dedication to academic advancement.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER SCIENCE

Dr. Cavalcanti's research endeavors are diverse and impactful. As the Head and Researcher of Clinical Microbiology at the Laboratory of Immunopathology Keizo Asami at UFPE (LIKA/UFPE), she spearheads investigations into drug delivery systems and their biological activities. Her research group, MicroNAT, focuses on innovative approaches to combat multi-drug-resistant bacteria and biofilm formation. Through her work, she seeks to advance pharmaceutical nanotechnology and fundamental microbiological understanding.

IMPACT AND INFLUENCE

Isabella MacƔrio Ferro Cavalcanti's contributions have had a profound impact on the fields of pharmaceutical nanotechnology and microbiology. Her research findings contribute to the development of novel therapeutic strategies and the understanding of microbial resistance mechanisms. As a respected member of the Brazilian Society of Microbiology and various scientific committees, her expertise is recognized nationally and internationally.

ACADEMIC CITATIONS

Dr. Cavalcanti's work has garnered significant attention within the academic community, reflected in numerous citations of her research publications. Her contributions to scientific literature serve as a foundation for further exploration and innovation in the fields of biotechnology, microbiology, and drug delivery.

LEGACY AND FUTURE CONTRIBUTIONS

With a strong foundation in academia and research, Dr. Cavalcanti's legacy is marked by her dedication to advancing knowledge and addressing critical healthcare challenges. Her leadership in research groups and academic programs ensures the continued development of future scientists and the pursuit of innovative solutions to complex biomedical problems. As she continues her career, her contributions are poised to further shape the landscape of biomedicine and microbiology, leaving a lasting legacy of excellence and innovation.

NOTABLE PUBLICATIONS

Zein nanoparticles containing ceftazidime and tobramycin: antibacterial activity against Gram-negative bacteria. 2024

Proteomic characterization and biological activities of the mucus produced by the zoanthid Palythoa caribaeorum (Duchassaing & Michelotti, 1860) 2023

Efficacy and non-toxicity of ciclopirox olamine-loaded liposomes against Cryptococcus neoformans clinical isolates. 2023

Gram-negative bacilli carrying mcr gene in Brazil: a pathogen on the rise. 2023

Antibiotic resistance profiles on pathogenic bacteria in the Brazilian environments. 2023